These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs. Langtry HD; Wilde MI Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317 [TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitors and acid-related diseases. Sachs G Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763 [TBL] [Abstract][Full Text] [Related]
26. Triple therapy as a cure for Helicobacter pylori infection. Bardhan KD Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S27-30. PubMed ID: 8930577 [TBL] [Abstract][Full Text] [Related]
28. [Peptic ulcer and Helicobacter pyrlori. Results and consequences of its eradication]. Ballesteros-Amozurrutia MA Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):41-9. PubMed ID: 11464621 [TBL] [Abstract][Full Text] [Related]
29. Effect of lansoprazole on peptic ulcers. Ohashi T; Sakata J; Haraguchi Y; Eto T J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350 [TBL] [Abstract][Full Text] [Related]
30. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Graham DY; Hammoud F; El-Zimaity HM; Kim JG; Osato MS; El-Serag HB Aliment Pharmacol Ther; 2003 May; 17(10):1229-36. PubMed ID: 12755836 [TBL] [Abstract][Full Text] [Related]
31. A review of omeprazole use in the treatment of acid-related disorders in children. Zimmermann AE; Walters JK; Katona BG; Souney PE; Levine D Clin Ther; 2001 May; 23(5):660-79; discussion 645. PubMed ID: 11394727 [TBL] [Abstract][Full Text] [Related]
32. Rabeprazole: a review of its use in acid-related gastrointestinal disorders. Langtry HD; Markham A Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440 [TBL] [Abstract][Full Text] [Related]
33. Acid and barriers. Current research and future developments for peptic ulcer therapy. Rademaker JW; Hunt RH Scand J Gastroenterol Suppl; 1990; 175():19-26. PubMed ID: 1978405 [TBL] [Abstract][Full Text] [Related]
34. An etiologic approach to management of duodenal and gastric ulcers. Rex DK J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053 [TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Graham DY Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000 [TBL] [Abstract][Full Text] [Related]
37. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview]. Leodolter A; Peitz U; Malfertheiner P Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994 [TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori eradication: therapy other than with bismuth or proton-pump inhibitors. Korman MG Scand J Gastroenterol Suppl; 1996; 220():41-3. PubMed ID: 8898434 [TBL] [Abstract][Full Text] [Related]
40. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication. Tan AC; Hartog GD; Mulder CJ Aliment Pharmacol Ther; 1999 Nov; 13(11):1519-22. PubMed ID: 10571610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]